68Ga-Nota-Abscint-Her2

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

2 Sponsors

3 Countries

Phase II/III

Phase I/II

Phase II/III: 1 Phase I/II: 1

Indications tested

HER2 positive breast cancer 1

Sponsors using this IMP

Abscint 1 Centre Henri Becquerel 1

All trials

2 total

Evaluation of a new radiotracker for predicting complete response after neoadjuvant chemotherapy in HER2-positive early breast cancer Pending

2025-523286-23-00 Phase I/II 1 country Centre Henri Becquerel
Evaluating the Diagnostic Performance of Human Epidermal Growth Factor Receptor 2 (HER2) targeted Positron Emission Tomography and Computed … Recruiting

2024-511419-22-00 Phase II/III 2 countries Abscint

Showing 1–2 of 2 trials

← All drugs A–Z